Advertisement

Topics

BRIEF—FDA approves dasatinib for pediatric patients with CML

12:23 EST 13 Nov 2017 | thePharmaLetter

The Food and Drug Administration granted regular approval for Sprycel (dasatinib) from Bristol-Myers…

Original Article: BRIEF—FDA approves dasatinib for pediatric patients with CML

NEXT ARTICLE

More From BioPortfolio on "BRIEF—FDA approves dasatinib for pediatric patients with CML"

Advertisement
Quick Search
Advertisement
Advertisement